查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1672731

按临床试验阶段、方法类型、服务供应商类型和地区分類的药物安全检测市场

Pharmacovigilance Market, By Clinical Trial Phases, By Type of Method, By Type of Service Provider, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 175 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2025 年全球药物安全检测市场规模估计为 80.3 亿美元，预计到 2032 年将达到 140.3 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 8.3%。

报告范围 报告详细信息
基准年 2024 2025 年市场规模 80.3亿美元
效能资料 2020-2024 预测期 2025-2032
预测期：2025 年至 2032 年复合年增长率 8.30％ 2032 年金额预测 140.3亿美元
市场占有率。
药物警戒市场-IMG1

近年来，全球药物安全检测市场经历了显着成长。药物安全检测是指与检测、评估、理解和预防副作用及其他与药物相关的问题的科学和活动。随着药物分子变得越来越复杂以及新治疗方法不断推向市场，对有效的上市后药物安全监测的需求也日益增加。严格的法律规范要求对药品进行安全监控，加上药物副作用的增加，推动了全球对药物安全检测服务的需求。此外，学名药市场的扩大和临床试验外包到新兴地区也进一步推动了药物安全检测市场的发展。

市场动态

全球药物安全检测市场受到药物不良反应增加、药品核准安全法规越来越严格、有效治疗方法需求不断增长以及学名药市场不断扩大的推动。要求上市后监测的严格监管准则是增加药物安全检测服务需求的一个主要因素。此外，因安全问题而召回药品的趋势日益增长，迫使製药公司将其药物安全检测业务委託给专业服务供应商。此外，已开发国家学名药市场的扩张为药物安全检测市场参与企业提供了重大机会。然而，中小企业的预算限制以及跨地区报告药品安全资料的复杂性对市场参与企业构成了挑战。

研究的主要特点

  • 本报告对全球药物安全检测市场进行了详细分析，并提供了预测期（2025-2032 年）的市场规模（十亿美元）和年复合成长率（CAGR%），假设基准年为 2024 年。
  • 它还强调了各个领域的潜在商机并说明了该市场的有吸引力的投资提案矩阵。
  • 它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
  • 它根据公司亮点、产品系列、关键亮点、财务表现和策略等参数，概述了全球药物安全检测市场的主要企业。
  • 本报告的见解将使负责人和企业经营团队能够就未来产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
  • 全球药物安全检测市场报告迎合了该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
  • 相关人员将透过全球药物安全检测市场分析中使用的各种策略矩阵更轻鬆地做出决策。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • 一致的机会图 (COM)

第三章市场动态、法规与趋势分析

  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
  • 影响分析
  • 市场趋势
  • 监管情景
  • 收购和合作场景
  • 资金筹措和投资
  • PEST分析
  • 波特的分析

第 4药物安全检测。

  • 整体影响
  • 政府倡议
  • COVID-19 市场影响

5. 2020 年至 2032 年按临床试验阶段分類的全球药物安全检测市场（十亿美元）

  • 介绍
  • 临床前研究
  • 临床试验 I 期
  • 临床试验 II 期
  • 临床试验 III 期
  • 上市后研究或 IV 期

6. 2020 年至 2032 年按方法类型分類的全球药物安全检测市场（十亿美元）

  • 介绍
  • 自发报道
  • 增强的 ADR 报告
  • 目标报告
  • 群组心臟事件记录器
  • 电子病历监控

7. 2020-2032 年全球药物安全检测市场（按服务供应商类型划分）（十亿美元）

  • 介绍
  • 内部
  • 合约外包

8. 2020 年至 2032 年全球药物安全检测市场（按地区划分）（单位：十亿美元）

  • 介绍
  • 北美洲
  • 拉丁美洲
  • 欧洲
  • 亚太地区
  • 中东
  • 非洲

第九章 竞争格局

  • 公司简介
    • Accenture
    • Cognizant Technology Solutions
    • Laboratory Corporation of America Holdings（LabCorp）
    • IBM Corporation
    • QuintilesIMS（IQVIA）
    • ICON plc
    • Capgemini
    • ITClinical
    • TAKE Solutions Ltd
    • BioClinica
    • PAREXEL International Corporation
    • Wipro Ltd
    • FMD K&L
    • Linical Accelovance
    • United BioSource Corporation（UBC）
    • PRA Health Sciences
    • ArisGlobal
    • Ennov Solutions Inc

第 10 章分析师建议

  • 兴衰
  • 一致的机会地图

第 11 章 参考文献与调查方法

  • 参考
  • 调查方法
简介目录
Product Code: CMI1047

Global Pharmacovigilance Market is estimated to be valued at USD 8.03 Bn in 2025 and is expected to reach USD 14.03 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.3% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 8.03 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 8.30% 2032 Value Projection: USD 14.03 Bn
Figure. Pharmacovigilance Market Share (%), By Region 2025
Pharmacovigilance Market - IMG1

The global pharmacovigilance market has been witnessing significant growth in the recent years. Pharmacovigilance is defined as the science and activities relating to the detection, assessment, understanding, prevention of adverse effects or any other drug-related problems. With the growing complexity of drug molecules and the introduction of novel therapies in the market, there is an increasing need to effectively monitor the safety of drugs post marketing. Stringent regulatory framework mandating drug safety monitoring along with increasing instances of adverse drug reactions is propelling the demand for pharmacovigilance services across the globe. Furthermore, the expanding generics market and outsourcing of clinical trials to emerging regions has further boosted the pharmacovigilance market.

Market Dynamics:

The global pharmacovigilance market is driven by the rising number of adverse drug reactions, stringent safety regulations for drug approval, increasing demand for efficacious therapies, and growing generics market. Stringent regulatory guidelines mandating post marketing surveillance is a key factor augmenting the demand for pharmacovigilance services. Furthermore, rising trend of drug recalls due to safety issues has compelled pharmaceutical companies to outsource their pharmacovigilance activities to specialized service providers. Moreover, increasing generics market in developed countries offer significant opportunities for the pharmacovigilance market players. However, budget constraints of small and midsize pharmaceutical companies and complexity of reporting drug safety data across regions pose challenges to market players.

Key Features of the Study:

  • This report provides in-depth analysis of the global pharmacovigilance market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global pharmacovigilance market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Accenture, Cognizant, Laboratory Corporation of America Holdings, IBM Corporation, ArisGlobal, ICON plc., Capgemini, ITClinical, FMD K&L, and IQVIA
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global pharmacovigilance market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pharmacovigilance market

Detailed Segmentation-

  • By Clinical Trial Phases
    • Total Knee Replacement
    • Partial Knee Replacement
    • Kneecap Replacement
    • Revision Knee Replacement
  • By Type of Method
    • Spontaneous Reporting
    • Intensified ADR Reporting
    • Targeted Reporting
    • Cohort Event Monitoring
    • EHR Monitoring
  • By Type of Service Provider
    • In-House
    • Contract Outsourcing
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Accenture
    • Cognizant Technology Solutions
    • Laboratory Corporation of America Holdings (LabCorp)
    • IBM Corporation
    • QuintilesIMS (IQVIA)
    • ICON plc
    • Capgemini
    • ITClinical
    • TAKE Solutions Ltd
    • BioClinica
    • PAREXEL International Corporation
    • Wipro Ltd
    • FMD K&L
    • Linical Accelovance
    • United BioSource Corporation (UBC)
    • PRA Health Sciences
    • ArisGlobal
    • Ennov Solutions Incc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Clinical Trial Phases
    • Market Snapshot, By Type of Method
    • Market Snapshot, By Type of Service Provider
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Pharmacovigilance Market - Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Pharmacovigilance Market, By Clinical Trial Phases, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Pre-clinical Studies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Clinical Trial Phase I
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Clinical Trial Phase II
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Clinical Trial Phase III
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Post Marketing Surveillance or Phase IV
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Pharmacovigilance Market, By Type of Method, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Spontaneous Reporting
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Intensified ADR Reporting
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Targeted Reporting
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Cohort Event Monitoring
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • EHR Monitoring
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Pharmacovigilance Market, By Type of Service Provider, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • In-House
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Contract Outsourcing
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Pharmacovigilance Market, By Region, 2020 - 2032, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2020-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phases, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Method, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Service Provider, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.S.
    • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phases, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Method, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Service Provider, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phases, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Method, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Service Provider, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phases, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Method, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Service Provider, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phases, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Method, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Service Provider, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phases, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Method, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Service Provider, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

  • Company Profiles
    • Accenture
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • Cognizant Technology Solutions
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • Laboratory Corporation of America Holdings (LabCorp)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • IBM Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • QuintilesIMS (IQVIA)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • ICON plc
    • Capgemini
    • ITClinical
    • TAKE Solutions Ltd
    • BioClinica
    • PAREXEL International Corporation
    • Wipro Ltd
    • FMD K&L
    • Linical Accelovance
    • United BioSource Corporation (UBC)
    • PRA Health Sciences
    • ArisGlobal
    • Ennov Solutions Inc

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About Us and Sales Contact